Total Payments
$9,597
2024 Payments
$319.19
Companies
57
Transactions
688
Medicare Patients
978
Medicare Billing
$25,715
Payment Breakdown by Category
Food & Beverage$9,587 (99.9%)
Education$10.43 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,587 | 684 | 99.9% |
| Education | $10.43 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,162 | 64 | $0 (2024) |
| Novo Nordisk Inc | $1,110 | 85 | $0 (2024) |
| GlaxoSmithKline, LLC. | $885.27 | 67 | $0 (2024) |
| PFIZER INC. | $867.09 | 74 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $821.48 | 65 | $0 (2022) |
| ABBVIE INC. | $594.94 | 50 | $0 (2024) |
| Amgen Inc. | $452.04 | 34 | $0 (2023) |
| Lilly USA, LLC | $444.23 | 33 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $400.33 | 29 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $267.76 | 20 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $319.19 | 17 | GlaxoSmithKline, LLC. ($59.40) |
| 2023 | $979.05 | 59 | AstraZeneca Pharmaceuticals LP ($205.74) |
| 2022 | $1,800 | 118 | ABBVIE INC. ($209.24) |
| 2021 | $1,513 | 113 | AbbVie Inc. ($345.75) |
| 2020 | $1,050 | 75 | Novo Nordisk Inc ($244.37) |
| 2019 | $854.63 | 63 | AstraZeneca Pharmaceuticals LP ($121.30) |
| 2018 | $1,396 | 105 | PFIZER INC. ($220.33) |
| 2017 | $1,686 | 138 | PFIZER INC. ($288.44) |
All Payment Transactions
688 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $39.85 | General |
| Category: SCHIZOPHRENIA | ||||||
| 07/09/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: VACCINES | ||||||
| 06/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Obesity | ||||||
| 06/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/20/2024 | Hologic Sales and Service, LLC | THINPREP 2000 PROCESSOR (Device), APTIMA | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Diagnostics | ||||||
| 06/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: RESPIRATORY | ||||||
| 06/04/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Gastroenterology | ||||||
| 05/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/14/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Cardio-renal | ||||||
| 05/06/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.37 | General |
| Category: NEUROLOGY | ||||||
| 04/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Diabetes | ||||||
| 04/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: RESPIRATORY | ||||||
| 03/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Bone Health | ||||||
| 12/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/01/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Oncology | ||||||
| 10/25/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 249 | 259 | $33,267 | $5,361 |
| 2022 | 5 | 266 | 271 | $36,018 | $6,607 |
| 2021 | 4 | 185 | 188 | $31,125 | $5,576 |
| 2020 | 7 | 278 | 321 | $45,194 | $8,171 |
Total Patients
978
Total Services
1,039
Medicare Billing
$25,715
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2023 | 14 | 14 | $13,944 | $2,267 | 16.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 124 | 126 | $6,426 | $1,182 | 18.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 64 | 65 | $3,705 | $937.84 | 25.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $8,052 | $585.79 | 7.3% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 23 | 28 | $1,008 | $345.80 | 34.3% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 13 | 15 | $131.70 | $42.70 | 32.4% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2022 | 23 | 23 | $22,908 | $3,602 | 15.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 155 | 155 | $7,905 | $1,625 | 20.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 53 | 53 | $3,021 | $840.21 | 27.8% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2022 | 22 | 24 | $1,608 | $340.17 | 21.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 13 | 16 | $576.00 | $200.10 | 34.7% |
| 45384 | Removal of tissue abnormalities, tumors, or polyps of large bowel by hot biopsy forceps, using a flexible endoscope | Facility | 2021 | 22 | 23 | $22,908 | $3,662 | 16.0% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 100 | 100 | $5,100 | $1,019 | 20.0% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 37 | 37 | $2,109 | $542.57 | 25.7% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 26 | 28 | $1,008 | $352.80 | 35.0% |
| 45384 | Removal of polyps or growths in large bowel using an endoscope | Facility | 2020 | 24 | 24 | $23,904 | $4,046 | 16.9% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2020 | 106 | 106 | $5,406 | $1,163 | 21.5% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2020 | 58 | 58 | $3,306 | $969.23 | 29.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 11 | 11 | $8,052 | $697.61 | 8.7% |
| 80305 | Testing for presence of drug | Office | 2020 | 44 | 54 | $1,944 | $675.15 | 34.7% |
| 93227 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg | Facility | 2020 | 21 | 21 | $1,407 | $418.23 | 29.7% |
| 85610 | Blood test, clotting time | Office | 2020 | 14 | 47 | $1,175 | $201.45 | 17.1% |
About Dr. David Byrd, MD
Dr. David Byrd, MD is a Family Medicine healthcare provider based in Athens, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447262449.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Byrd, MD has received a total of $9,597 in payments from pharmaceutical and medical device companies, with $319.19 received in 2024. These payments were reported across 688 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($9,587).
As a Medicare-enrolled provider, Byrd has provided services to 978 Medicare beneficiaries, totaling 1,039 services with total Medicare billing of $25,715. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Athens, TN
- Active Since 08/12/2006
- Last Updated 07/09/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1447262449
Products in Payments
- FARXIGA (Drug) $749.60
- TRELEGY ELLIPTA (Drug) $549.67
- JARDIANCE (Drug) $392.41
- Ozempic (Drug) $390.45
- XARELTO (Drug) $359.87
- TRULICITY (Drug) $301.33
- CHANTIX (Drug) $279.53
- VRAYLAR (Drug) $278.92
- Victoza (Drug) $259.42
- ELIQUIS (Drug) $250.72
- ENTRESTO (Drug) $213.50
- XIFAXAN (Drug) $188.32
- UBRELVY (Drug) $171.54
- Kerendia (Drug) $157.74
- BREZTRI (Drug) $151.57
- REXULTI (Drug) $147.39
- Aimovig (Biological) $145.83
- SPIRIVA RESPIMAT (Drug) $138.29
- VIAGRA (Drug) $137.20
- LINZESS (Drug) $134.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Athens
Farris Johnson, Md, MD
Family Medicine — Payments: $30,847
Family Medicine $30,847
Timothy Law, Do, DO
Family Medicine — Payments: $18,254
Family Medicine $18,254
Dr. Henry Morris, M.d, M.D
Family Medicine — Payments: $16,624
Family Medicine $16,624
Alvin Wilson, D.o, D.O
Family Medicine — Payments: $13,833
Family Medicine $13,833
Dr. James Shiver, M.d, M.D
Family Medicine — Payments: $13,306
Family Medicine $13,306
Dr. Paul Haver, M.d, M.D
Family Medicine — Payments: $11,681
Family Medicine $11,681